Hypertropia

Hypertropia is a condition of the eye where one eye is misaligned and points upwards. It is a type of strabismus, which is a general term for misalignment of the eyes. Hypertropia can be present all the time, or it can come and go. It can also occur together with other types of strabismus, such as exotropia (outward turning of the eye) or esotropia (inward turning of the eye).

Causes

Hypertropia can be caused by a number of factors, including:

• Nerve damage or muscle damage: Damage to the nerves or muscles that control eye movement can lead to hypertropia. This can be caused by conditions such as stroke, brain tumor, or trauma to the eye or brain.
• Congenital conditions: Some people are born with hypertropia. This can be due to a problem with the development of the eye muscles or nerves in the womb.
• Disease or infection: Certain diseases or infections can cause hypertropia. For example, Graves' disease can cause swelling and inflammation of the eye muscles, leading to hypertropia.

Symptoms

The main symptom of hypertropia is one eye that points upwards. Other symptoms can include:

• Double vision: Seeing two images of a single object.
• Head tilt: Tilting the head to one side to compensate for the misaligned eye.
• Eye strain: Feeling of discomfort or fatigue in the eyes.
• Difficulty reading: Trouble focusing on text or other close-up tasks.

Treatment

Treatment for hypertropia depends on the cause and severity of the condition. Options can include:

• Eye exercises: Certain exercises can help strengthen the eye muscles and improve alignment.
• Glasses or contact lenses: These can help correct the misalignment in some cases.
• Surgery: In severe cases, surgery may be needed to adjust the position of the eye muscles.
• Botox injections: These can help relax the eye muscles and improve alignment.

See also

• Strabismus
• Exotropia
• Esotropia
• Graves' disease

Hypertropia Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.